Moat Biotechnology Corporation
1 clinical trials · Sponsor
◉ Watch Moat Biotechnology Corporation
| Record | Firm | Date |
|---|---|---|
| A Phase 1, First-In-Human Study of the Investigational COVID-19 Vaccine SC-Ad6-1 in Healthy Volunteers (NCT04839042) | Moat Biotechnology Corporation | 2021-06-28 |
Track Moat Biotechnology Corporation automatically
Every clearance here is in the API, with alerts when new ones post.